Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph MortonMarch 26, 2026
Medical and Pharmaceutical Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug The approval marked a pivotal milestone for the company, transitioning it from a clinical-stage entity to a commercial-stage player Joseph MortonSeptember 5, 2025